Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03228693 · ClinicalTrials.gov registry record · NA
Gene Expression and Biomarker Profiling of Keloid Skin
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03228693 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 48 participants.
The verdict
NCT03228693, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This study aims to examine both the genetic profile and the biomarkers implicated in keloid scar formation. Hypothesis: 1. Differences in the genetic profiles of lesional and non-lesional skin contribute a given population's propensity to develop keloids 2. Differences in biomolecules expressed in subjects with and without keloids can help predict keloid occurrence and severity 3. Biomarker analysis will provide useful insights for future targeted therapies for keloid scars
Interventions
- PROCEDURE Excisional Biopsy
- PROCEDURE Biopsy and/or triamcinolone injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03228693
The ClinicalTrials.gov registry entry for NCT03228693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Excisional Biopsy is the first listed.
NCT03228693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03228693 about?
NCT03228693 is a clinical study titled "Gene Expression and Biomarker Profiling of Keloid Skin". This study aims to examine both the genetic profile and the biomarkers implicated in keloid scar formation. Hypothesis: 1. Differences in the genetic profiles of lesional and non-lesional skin contribute a given population's propensity to develop keloids 2. Differences in biomolecules expressed in...
What is the current status of trial NCT03228693?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2017-09-11. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03228693?
The interventions under investigation include: Excisional Biopsy (PROCEDURE), Biopsy and/or triamcinolone injection (PROCEDURE).
Who is sponsoring clinical trial NCT03228693?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.